Sunday, August 16, 2026 Never miss a recall or a rule change Go Pro · $20/mo →
Inside MedSpa
FDA Recall & Compliance Alerts for Medspa Owners
InjectablesHugel Posts Record H1 on Toxin Surge—Overseas Growth AcceleratestodayMarketHugel Posts Record H1 Revenue on Overseas Toxin Surge3 days agoDevices & TechApyx: GLP-1 Boom Is Fueling Renuvion DemandtodayMarketMedytox Q2 Sales Up 11%, Operating Profit Down 25%3 days agoInjectablesGalderma Wins EU Nod for Restylane ShaypeyesterdayBusiness & M&AEstablishment Labs Raises 2026 Revenue Guidance2 days agoDevices & TechMerz Ultherapy PRIME Clears FDA for Knee Skin LaxityyesterdayBusiness & M&ABeauty Health Q2 Earnings: Device Demand Steady2 days agoInjectablesHugel Debuts Thechaum Signature with Reduced CrosslinkeryesterdayDevices & TechAlma Launches TitaniumLift™ Multi-Depth RF Protocol2 days agoInjectablesGLP-1 Boom Exposed Filler Limitations—Here's WhyyesterdayInjectablesGalderma Chief: Start GLP-1 Patients on Skin Care First2 days ago
Trade & Tariffs

Export Controls

Rules restricting which technologies U.S. firms can ship abroad, central to the chip and AI trade war.

Also known as: EAR, Export Administration Regulations

What it is
Export controls are U.S. rules, chiefly the Export Administration Regulations administered by the Commerce Department's BIS, that restrict exports of sensitive goods and technology. They govern semiconductors, tooling, and dual-use items. Licenses may be required or denied.
What it does
New controls can cut off a lucrative export market for chipmakers and equipment vendors, capping revenue and forcing product redesigns. Investors gauge each company's China or restricted-market exposure. Announcements move semiconductor and equipment names sharply.
The evidence
Tightened controls on advanced chips and lithography tools have curtailed China-market sales for U.S. and allied semiconductor firms.
Best for
Chip and equipment names like NVDA, AMD, LRCX, AMAT, KLAC.
Pairs well with
entity-list, sanctions, chips-act
Use cautiously with
Companies often design compliant products to keep selling; assuming controls zero out a market can overstate the damage.
Cautions
Rules are frequently revised, and license outcomes are opaque, making the revenue hit hard to size.
General information, not medical advice. Ingredient effects vary by formulation, concentration, and skin. Patch-test new actives and consult a qualified provider before starting prescription ingredients.

Know what's coming before your patients ask for it.

New actives, device launches, and the FDA calls that change what you can offer — distilled into a two-minute brief, twice a week. Inside MedSpa Pro.

Go Pro · $20/mo
Inside MedSpa Pro

By the time it's news, it's too late.

The rebate cut, the scope-of-practice bill, the competitor opening down the street — it hits your business before the trade press ever covers it. Pro gets you there first: what happened, why it touches your margins, and exactly what to do — at 6 AM, in two minutes.

Go Pro · $20/mo Never miss a recall or a rule change. Cancel anytime.
The twice-a-week intelligence brief Go Pro · $20/mo